fluorodeoxyglucose f18 has been researched along with Squamous Cell Carcinoma of Head and Neck in 220 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 117 (53.18) | 24.3611 |
| 2020's | 103 (46.82) | 2.80 |
| Authors | Studies |
|---|---|
| Deraniyagala, R; Grzywacz, VP; Hanna, A; Krauss, DJ; Wilson, GD; Wilson, TG; Yan, A; Yan, D | 1 |
| Aryal, M; Bhambhani, C; Bhangale, A; Brenner, JC; Brummel, C; Cao, Y; Casper, K; Chinn, S; Gu, W; Haring, CT; Heft Neal, M; Lee, C; Malloy, K; McHugh, JB; Mierzwa, M; Mills, RE; Prince, ME; Schonewolf, C; Shah, J; Shuman, A; Spector, ME; Sun, Y; Swiecicki, PL; Tewari, M; Worden, FP | 1 |
| Al-Mamgani, A; Baris Karakullukcu, M; Bing Tan, I; Blank, CU; Broeks, A; de Boer, JP; Dirven, R; Elbers, JBW; Haanen, JBAG; Hooijberg, E; Jasperse, B; Karssemakers, L; Keijser, A; Klop, WMC; Krijgsman, O; Lohuis, PJFM; Lubeck, Y; Onderwater, S; Peeper, DS; Qiao, X; Schreuder, WH; Schumacher, TN; Seignette, IM; Smeele, LE; Smit, LA; Traets, JJH; van den Brekel, MWM; van der Leun, AM; van der Noort, V; van der Velden, LA; Vogel, WV; Vos, JL; Willems, SM; Zuur, CL | 1 |
| Chen, YH; Cheng, SC; Guenette, J; Gunasti, L; Haddad, R; Jacene, HA; Jo, VY; Lako, A; Rodig, S; Schoenfeld, JD; Shah, H; Uppaluri, R; Wang, Y | 1 |
| Evans, J; Hardman, J; McLaren, O; Williams, R; Zhu, Y | 1 |
| Hirosue, A; Kawahara, K; Kitajima, M; Minamitake, A; Murakami, R; Nakayama, H; Sakamoto, F; Sakata, J; Shiraishi, S; Yamana, K; Yoshida, R | 1 |
| Ludlow, D; Muller, RG; Weidenbecher, M | 1 |
| Abdalla, AS; Khan, SA; Sheybani, ND | 1 |
| Gu, H; Li, M; Wang, Y; Wu, J; Xuan, G | 1 |
| Abe, T; Endo, T; Kaswasaki, Y; Kouga, T; Suzuki, S; Toyoma, S; Yamada, T | 1 |
| Beaty, BM; Benefield, T; Chera, B; Jewells, VL; Muhleman, MA; Oldan, JD | 1 |
| Chan, C; Cheng Lau, Y; Dempsey, MF; Dyab, H; Grose, D; Hendry, F; James, A; Lamb, C; Maxfield, C; Paterson, C; Rulach, R; Schipani, S; Wilson, C; Zhou, S | 1 |
| Bedmutha, A; Kaushal, A | 1 |
| Alavi, A; Asadollahi, S; Kaghazchi, F; Korostoff, J; Mehdizadeh Seraj, S; Raynor, WY; Revheim, ME; Seierstad, T; Swisher-McClure, S; Werner, TJ; Zirakchian Zadeh, M | 1 |
| Hyayashi, T; Nikkuni, Y; Nishiyama, H | 1 |
| Burian, E; Callahan, N; Froelich, MF; Gassert, FG; Makowski, MR; Palla, B; Pyka, T; Rübenthaler, J; Schmid, A; von Schacky, CE; Wolff, C | 1 |
| Akhtar, F; Beadle, BM; Colevas, AD; Divi, V; Gensheimer, MF; Harandi, N; Holsinger, FC; Le, QT; Liang, R; Liu, Y; Miller, JA; Moradi, F; Nguyen, NK; Pollom, EL; Ren, Y; Sundaram, V; Weng, Y; Zhang, C | 1 |
| Azevedo, EC; Baik, FM; Castillo, J; Chin, FT; Colevas, AD; Duan, H; Ferri, V; Freeman, L; Hom, M; Iagaru, A; Kaplan, MJ; Koran, ME; Lee, YJ; Martin, BA; Raymundo, RC; Rosenthal, EL; Shen, B; Valencia, A; van den Berg, NS; Zhou, Q | 1 |
| Aebersold, DM; Alberts, I; Bojaxhiu, B; Elicin, O; Rominger, A; Shelan, M; Sinovcic, D; Templeton, AJ; Wartenberg, J; Zaugg, K | 1 |
| Bunch, PM; Evans, JK; Farris, JC; Hughes, RT; Johnson, AG; Patel, Z; Schroeder, JA; Steber, CR | 1 |
| Bolt, H; Cheriyan, S; Cook, L; Hopkins, J; Mair, M; Noor, A; Ooi, EH; Woods, CM | 1 |
| Cui, Y; Jin, A; Lin, X; Ma, L; Yin, X | 1 |
| Cardin, A; Dhillon, K; Dixon, B; Flatman, S; Fua, T; J R Magarey, M; Kleid, S; Manji, J; Prasad, J; Rischin, D; Tapia, M | 1 |
| Aren, E; Berry, M; Deshpande, S; Estall, V; Fowler, A; Jameson, MG; Johnston, M; Lee, M; Trada, Y | 1 |
| Chaushu, H; Even-Sapir, E; Gutfeld, O; Holan, A; Horowitz, G; Kampel, L; Muhanna, N; Nachalon, Y; Nard-Carmel, N; Oestraicher, Y; Ospovat, I; Oz, YN; Shapira, U; Ungar, O; Warshavsky, A | 1 |
| Erdogan, ST; Flygare, L; Söderkvist, K | 1 |
| Born, D; Broglie, MA; Hüllner, MW; Kovacs, Z; Maurer, A; Morand, GB; Nemes, CM; Nemmour, A; Pazahr, S; Rupp, NJ; Serrallach, B; Stadler, TM; Stoeckli, SJ | 1 |
| Cho, H; Jo, KH; Kang, WJ; Kim, J; Lee, SK; Park, K; Sohn, B; Woo, C | 1 |
| Kim, M; Ogawa, M; Palangka, CRAP; Seki-Soda, M; Shimizu, T; Takayama, Y; Yokoo, S | 1 |
| Doai, M; Matoba, M; Nagata, H; Nishino, Y; Ota, K; Tsuchiya, H; Tuji, H | 1 |
| Chen, M; Chen, TM; Chen, WM; Shia, BC; Wu, SY | 1 |
| Agarwal, JP; Budrukkar, A; Ghosh-Laskar, S; Gupta, T; Joshi, A; Joshi, K; Kumar, A; Nair, S; Paul, S; Prabhash, K; Purandare, N; Rangarajan, V; Sinha, S; Swain, M | 1 |
| Allen, SG; Aryal, M; Brenner, JC; Cao, Y; Casper, KA; Chinn, SB; Elliott, DA; Malloy, KM; Mierzwa, ML; Prince, ME; Rosen, BS; Rosko, AJ; Schipper, MJ; Schonewolf, CA; Shah, JL; Shuman, AG; Spector, ME; Stucken, CL; Swiecicki, PL; Wong, KK; Worden, FP | 1 |
| Feng, J; Gao, X; He, Y; Hu, Y; Ma, Y; Pan, Y; Peng, L; Xu, F; Zhu, X | 1 |
| Röhrich, M | 1 |
| Abd El-Gaid, S; Ashraf, A; Elahmadawy, MA; Kotb, M; Moustafa, H | 1 |
| Kirita, T; Nakayama, Y; Tamaki, S; Ueda, N; Yagyuu, T; Yamakawa, N | 1 |
| Boyle, JO; Chen, L; Cohen, MA; Cracchiolo, JR; Dunn, L; Ganly, I; Gelblum, DY; Kang, JJ; Lee, NY; McBride, SM; Michel, LS; Patel, SG; Pfister, DG; Riaz, N; Schöder, H; Sherman, EJ; Singh, B; Tsai, CJ; Wong, RJ; Yu, Y; Zakeri, K | 1 |
| Bartolomei, M; Bianchini, C; Bonsembiante, A; Caracciolo, M; Carandina, I; Ciorba, A; Cittanti, C; Corazzi, V; Migliorelli, A; Ortolan, N; Panareo, S; Pelucchi, S; Uccelli, L; Urso, L | 1 |
| Calais, J; Czernin, J; Hotta, M; Howard, T; Maliha, PG; Mendelsohn, AH | 1 |
| Atay, LO; Aydos, U; Cebeci, S; Duzlu, M; Pula, D; Yeniceri, A; Yilmaz, M | 1 |
| Beppu, S; Hanai, N; Kodaira, T; Nishikawa, D; Nishio, M; Sasaki, E; Sawabe, M; Suzuki, H; Tamaki, T; Terada, H | 1 |
| McKiddie, F; Nath, M; Philip, MM; Welch, A | 1 |
| Hellström, H; Kemppainen, J; Klén, R; Liedes, J; Malaspina, S; Rainio, O | 1 |
| Bernsdorf, M; Friborg, J; Gothelf, A; Håkansson, K; Kristensen, CA; Lindegaard, AM; Specht, L; Vogelius, I | 1 |
| Daisaki, H; Enomoto, A; Ishii, K; Ito, K; Kaida, H; Kimura, T; Kitajima, K; Otsuki, N; Sato, MP; Sekine, T | 1 |
| Abgral, R; Clément, C; Gujral, DM; Le Gal, G; Le Pennec, R; Leclère, JC; Maheo, C; Marianowski, R; Salaun, PY; Schick, U | 1 |
| Chan, C; Dempsey, MF; Dyab, H; Grose, D; Hendry, F; James, A; Lamb, C; Lau, YC; Maxfield, C; Paterson, C; Rulach, R; Schipani, S; Wilson, C; Zhou, S | 1 |
| Duvernay, J; Majoufre, C; Schlund, M | 1 |
| Dijkema, T; Doornaert, PAH; Hoeben, BAW; Kaanders, JHAM; Kasperts, N; Smid, EJ; Terhaard, CHJ; van den Bosch, S; Verhoef, LCG; Zwijnenburg, EM | 1 |
| Arunsingh, M; Dyker, KE; Prestwich, RJD; Scarsbrook, AF; Vaidyanathan, S; Zhong, J | 1 |
| Agarwal, JP; Arya, S; Budrukkar, A; Chatterjee, A; Ghosh-Laskar, S; Gupta, T; Murthy, V; Purandare, N; Rangarajan, V | 1 |
| Shahid, A; Younis, MN | 1 |
| Gundermann, P; Meyer, HJ; Surov, A | 1 |
| Christensen, JT; Fischer, BM; Friborg, J; Håkansson, K; Jensen, JS; Löfgren, J; Rasmussen, JH; Vogelius, IR; von Buchwald, C; Zamani, M | 1 |
| Dhomps, A; Dumollard, JM; Froudarakis, M; Gavid, M; Karpathiou, G; Lelonge, Y; Peoc'h, M; Prades, JM; Prevot-Bitot, N; Vieville, M | 1 |
| Akazawa, T; Aoki, M; Asano, T; Inoue, N; Ito, Y; Kato, H; Kuze, B; Matsuo, M; Miyazaki, T; Ohashi, T; Shibata, H; Terasawa, K | 1 |
| Benevolo, M; Farneti, A; Gangemi, E; Marzi, S; Pasqualoni, R; Pellini, R; Rollo, F; Ruberto, E; Sanguineti, G; Sciuto, R; Spasiano, F; Sperati, F; Vidiri, A | 1 |
| Currie, S; Dyker, K; Prestwich, R; Scarsbrook, A; Sundersingh, M; Vaidyanathan, S; Zhong, J | 1 |
| Chen, X; Chen, Y; Dang, H; Hou, B; Jin, Z; Shi, X; Xing, H; Xue, H; Zhang, Z; Zhu, X | 1 |
| Arimura, H; Kai, Y; Matsuyama, T; Murakami, D; Nakayama, H; Orita, Y; Oya, N; Saito, T; Sakamoto, F; Shiraishi, S; Toya, R; Tsuda, N; Watakabe, T; Yoshida, R | 1 |
| Arioka, T; Fukuhara, R; Fukuma, S; Hiraki, T; Kaji, M; Kanazawa, S; Marunaka, H; Masaoka, Y; Ogawa, N; Shinya, T; Tanaka, T | 1 |
| Al-Mamgani, A; Gouw, ZAR; La Fontaine, MD; Sonke, JJ; van de Kamer, JB; Vogel, WV | 1 |
| Delidis, A; Economopoulou, P; Giotakis, E; Kalkanis, D; Maragkoudakis, P; Psyrri, A; Sakagiannis, G; Zacharatou, A | 1 |
| Dorgelo, B; Fazzi, M; Hanemaaijer, SH; Oosting, SF; Plaat, BEC; Steenbakkers, RJHM; Stormezand, GN; van der Laan, BFAM; van der Vegt, B; Witjes, MJH | 1 |
| Andersen, FL; Bentzen, SM; Fischer, BM; Hansen, AE; Johannesen, HH; Kjær, A; Lelkaitis, G; Olin, A; Rasmussen, JH; Specht, L; Vogelius, IR; von Buchwald, C; Wessel, I | 1 |
| Barney, CL; Bhatt, A; Blakaj, D; Diavolitsis, V; Eckstein, JM; Gamez, M; Grecula, JC; Healy, E; Jain, A; McElroy, JP; Miller, E; Mitchell, DL; Nolan, N; Washington, I; Wobb, JL; Wright, CL | 1 |
| De Felice, F; Guerrero Urbano, T; Humbert-Vidan, L; King, A; Lei, M | 1 |
| Branstetter, BF; Duvvuri, U; Heron, DE; Ly, JD; Rath, TJ; Wangaryattawanich, P | 1 |
| Andreu-Arasa, VC; Fujima, N; Meibom, SK; Mercier, GA; Sakai, O; Salama, AR; Truong, MT | 2 |
| Dempsey, MF; Grose, D; Hendry, F; James, A; Lamb, C; Lau, YC; Paterson, C; Rizwanullah, M; Rulach, R; Schipani, S; Stobo, D; Wilson, C; Zhou, S | 1 |
| Earls, P; Emmett, L; Gallagher, R; Ho, B; Lee, J; Matthews, T; Tang, R | 1 |
| Boellaard, R; Castelijns, JA; de Bree, R; de Graaf, P; Koopman, T; Leemans, CR; Martens, RM; Noij, DP; Vergeer, MR; Zwezerijnen, G | 1 |
| Chakravorty, N; Chatterjee, S; Ghosh, S; Mallick, I; Maulik, S; Mukherjee, J | 1 |
| Arnold, C; Dejaco, D; Kofler, B; Moser, P; Riechelmann, H; Riedl, D; Schartinger, VH; Steinbichler, TB; Uprimny, C; Virgolini, I; Widmann, G | 1 |
| Broglie, MA; Hüllner, MW; Morand, GB; Stadler, TM | 1 |
| Bradford, C; Casper, KA; Chapman, CH; Chinn, SB; Chotchutipan, T; Eisbruch, A; Ibrahim, M; Malloy, KM; McLean, SA; Mierzwa, ML; Miller, JE; Prince, MEP; Rosen, BS; Rosko, AJ; Schonewolf, CA; Shah, JL; Shuman, AG; Spector, ME; Stucken, CL; Sun, Y; Swiecicki, PL; Wilkie, JR; Worden, FP | 1 |
| Amini, A; Eguchi, MM; Goddard, JA; Karam, SD; McDermott, J; Morgan, RL; Mueller, AC; Trivedi, PS | 1 |
| Aldaly, M; Alsayed, Y; Darwish, H; Kandeel, A; Saied, M | 1 |
| Flavell, RR; Ha, PK; Strohl, MP; Yom, SS | 1 |
| Fukusumi, T; Hanamoto, A; Inohara, H; Isohashi, F; Kishikawa, T; Michiba, T; Ogawa, K; Seo, Y; Suzuki, M; Takemoto, N; Tamari, K; Tanaka, H; Tatsumi, M | 1 |
| Ishibashi, K; Kato, I; Kimura, M; Nagao, T; Sone, Y; Umemura, M | 1 |
| Goel, A; Patel, Y; Rana, D; Saini, SK; Srivastava, S; Suryanarayana, K | 1 |
| Arens, C; Eckert, A; Grosser, O; Pech, M; Surov, A; Wienke, A | 1 |
| Ha, S; Kim, J; Kwon, SJ; O, JH; Park, SY; Yoo, IR; Yoon, H | 1 |
| Basso, L; Cavaliere, C; Garbino, N; Nicolai, E; Pace, L; Salvatore, M; Spinato, G | 1 |
| Benjamin, J; Hephzibah, J; Mathew, D; Oommen, R; Pavamani, S; Rajnikanth, J; Shanthly, N | 1 |
| Broglie, MA; Hüllner, MW; Morand, GB; Rupp, NJ; Stadler, TM | 1 |
| Andersen, FL; Bentzen, SM; Fischer, BM; Hansen, AE; Johannesen, HH; Kjaer, A; Lelkaitis, G; Olin, AB; Rasmussen, JH; Specht, L; Vogelius, IR; von Buchwald, C; Wessel, I | 1 |
| Bley, TA; Brands, RC; Brumberg, J; Buck, AK; Dierks, A; Hartmann, S; Haug, L; Herterich, T; Kertels, O; Kübler, AC; Lapa, C; Linz, C; Müller-Richter, U | 1 |
| Furukawa, M; Hanai, N; Sato, Y; Shimode, Y; Terada, H | 1 |
| Cai, J; Cheng, NM; Huo, Y; Lee, LY; Liao, CT; Lin, CY; Lu, L; Nogues, I; Wang, HM; Xiao, J; Yao, J; Ye, X; Yen, TC; Zhang, L; Zhao, K; Zhao, S; Zhou, W | 1 |
| Kave, M; Parooie, F; Sadegi, K; Salarzaei, M | 1 |
| Bernsdorf, M; Berthelsen, AK; Friborg, J; Gothelf, AB; Kjems, J; Kristensen, CA; Loft, A; Vogelius, IR; von Buchwald, C | 1 |
| Aringhieri, G; Bola, S; Faggioni, L; Garau, LM; Manca, G; Volterrani, D | 1 |
| Marcus, C; Subramaniam, RM | 1 |
| Anjari, M; Bassett, P; Connor, S; Cook, G; Goh, V; Guerrero-Urbano, T; Lei, M; Sit, C; Szyszko, T | 1 |
| Kojima, I; Kouketsu, A; Kumamoto, H; Miyashita, H; Mori, S; Murata, T; Nagai, H; Nogami, S; Sakamoto, M; Takahashi, T; Yamauchi, K | 1 |
| Chen, MYC; Hsu, JT; Lin, NC; Su, IH; Tsai, KY | 1 |
| Andreu-Arasa, VC; Fujima, N; Hirata, K; Homma, A; Kano, S; Kudo, K; Meibom, SK; Mercier, GA; Sakai, O; Truong, MT; Yasuda, K | 1 |
| Bray, V; Fowler, A; Holloway, L; Lai, K; Lee, CS; Lee, M; Lin, P; Min, M; Xuan, W; Yong, J | 1 |
| Agazzi, GM; Albano, D; Bertagna, F; Bosio, P; Farina, D; Giubbini, R; Grammatica, A; Lancini, D; Maroldi, R; Nicolai, P; Piazza, C; Ravanelli, M; Squassina, G; Zigliani, A | 1 |
| de Patoul, N; Denis, JM; Differding, S; Grégoire, V; Hermand, N; Lee, JA; Nuyts, S; Sterpin, E; Vanstraelen, B | 1 |
| Abraham, T; Bello, JA; Cho, JK; Gulko, E; Lee, AY; Lin, J; Moadel, RM; Neimark, M; Ow, TJ; Schiff, BA; Schlecht, NF; Shifteh, K; Smith, RV; Tassler, AB; Ustun, B; Valdivia, A | 1 |
| Goel, R; Khan, S; Moore, W; Sher, D; Subramaniam, RM; Sumer, B | 1 |
| Carp, L; Helsen, N; Roothans, D; Stroobants, S; Van Den Heuvel, B; Van den Weyngaert, D; Van den Wyngaert, T | 1 |
| Becker, CD; Becker, M; Burkhardt, K; Caparrotti, F; Combescure, C; Delattre, BMA; Dulguerov, N; Dulguerov, P; Katirtzidou, E; Pusztaszeri, M; Rager, O; Ratib, O; Varoquaux, AD; Zaidi, H | 1 |
| de Bree, R; de Keizer, B; Ferlito, A; Forastiere, AA; Haigentz, M; Hartl, DM; Nixon, IJ; Rinaldo, A; Rodrigo, JP; Saba, NF; Suárez, C; Vermorken, JB; Wolf, GT | 1 |
| Berwouts, D; Bonte, K; Boterberg, T; De Neve, W; Deron, P; Duprez, F; Goethals, I; Huvenne, W; Madani, I; Olteanu, AL; Vercauteren, T | 1 |
| Choi, YJ; Jang, JY; Ki, YK; Kim, H; Kim, IJ; Kim, SJ; Kim, WT; Pak, KJ; Seol, YM; Wang, SG; Yi, KI | 1 |
| Bogowicz, M; Guckenberger, M; Konukoglu, E; Lambin, P; Leijenaar, RTH; Pruschy, M; Riesterer, O; Studer, G; Tanadini-Lang, S; Unkelbach, J | 1 |
| Chen, RY; Chen, SW; Hsieh, TC; Kao, CH; Lin, YC; Shen, WC; Yen, KY | 1 |
| Ermiş, E; Philip, J; Prestwich, RJD; Scarsbrook, AF; Sen, M; Slevin, F; Vaidyanathan, S | 1 |
| Bianchi, R; Bossi, P; Canevari, S; Clement, PM; Coropciuc, R; Crippa, F; De Cecco, L; de Saint Aubain, N; Duprez, T; Fortpied, C; Guzzo, M; Hauben, E; Lalami, Y; Lemort, M; Lhommel, R; Lia, M; Licitra, LF; Liu, Y; Machiels, JP; Menis, J; Quattrone, P; Quiriny, M; Schmitz, S | 1 |
| Castelijns, JA; de Bree, R; Deurvorst, SE; Hoekstra, OS; Leemans, CR; Witte, BI | 1 |
| Coca-Pelaz, A; de Bree, R; Ferlito, A; Kowalski, L; Leemans, CR; Lopez, F; Mendenhall, W; Quer, M; Rinaldo, A; Senft, A; Shaha, AR; Silver, CE; Strojan, P; Takes, RP | 1 |
| Aryal, M; Cao, Y; Eisbruch, A; Hawkins, PG; Lee, C; Lee, J; Mierzwa, M; Shen, X; Teng, F | 1 |
| Liu, Y | 1 |
| Doi, H; Fujita, M; Fujiwara, M; Katsuura, T; Kitajima, K; Noguchi, K; Tamaki, Y; Terada, T; Tsuchitani, T; Uwa, N; Yamakado, K; Yoshida, R | 1 |
| Bacigalupo, A; Bianchi, A; Bonomo, P; Caini, S; Desideri, I; Franco, P; Franzese, C; Livi, L; Merlotti, A; Olmetto, E; Orlandi, E | 1 |
| Huber, GF; Huellner, MW; Meerwein, CM; Morand, GB; Nakadate, M; Stolzmann, P; Vital, D; Zweifel, DF | 1 |
| Dijkema, T; Hoebers, FJP; Kaanders, JHAM; Oyen, WJG; Philippens, MEP; Terhaard, CHJ; van den Bosch, S | 1 |
| Alves, MS; Andrade, LB; Barbosa, PNVP; Bes, PC; Calsavara, VF; Cezana, L; de Carvalho, GB; de Jesus, VHF; de Oliveira, TB; de Paiva, TF; Guimarães, APG; Kowalski, LP; Lima, ENP; Nicolau, UR; Pellizzon, ACA; Porto, GCLM; Silva, VS | 1 |
| Branstetter, BF; Clump, DA; Heron, DE; Hughes, M; Rath, TJ; Wangaryattawanich, P | 1 |
| Meyer, HJ; Purz, S; Sabri, O; Surov, A | 1 |
| Amdal, CD; Bogsrud, TV; Dale, E; Evensen, ME; Furre, T; Malinen, E; Moan, JM; Skjøtskift, T | 1 |
| Chen, DL; Mittra, E; Nadel, H; Niederkohr, RD; Sanli, Y; Subramaniam, RM; Zukotynski, K | 1 |
| Connor, S; Cook, GJ; Dunn, J; Guerrero-Urbano, T; Jeannon, JP; Lei, M; Oakley, R; Pencharz, D; Siddiqui, A; Sriskandan, N; Szyszko, TA; Thavaraj, S | 1 |
| Dankbaar, JW; de Boer, M; de Bree, R; de Keizer, B; Peltenburg, B; Philippens, MEP; Terhaard, CHJ; Willems, SM | 1 |
| Abgral, R; Bourhis, D; Delcroix, O; Gobel, Y; Guezennec, C; Orlhac, F; Robin, P; Rousset, J; Salaün, PY; Schick, U | 1 |
| Avril, NE; Awan, MJ; Chang, T; Chen, N; Fowler, N; Lavertu, P; Li, Y; Machtay, M; Rezaee, R; Wasman, J; Yao, M; Zender, C | 1 |
| de Bree, R; Driessen, JP; Huijbregts, JE; Janssen, LM; Pameijer, FA; Peltenburg, B; Philippens, MEP; Terhaard, CHJ | 1 |
| Anderson, C; Graham, M; Mallak, N; Mayo, Z; Menda, Y; Mott, SL; Seyedin, SN | 1 |
| Fukumura, M; Ishibashi, K; Kato, I; Kimura, M; Nagao, T; Nishiwaki, S; Shibata, A; Sone, Y; Umemura, M | 1 |
| Branstetter Iv, BF; Cramer, JD; Ferris, RL | 1 |
| Asmussen, JT; Bjørndal, K; Diaz, A; Døssing, H; Gerke, O; Godballe, C; Gyldenkerne, N; Høilund-Carlsen, PF; Johansen, J; Nielsen, AL; Pareek, M; Rohde, M; Sørensen, JA; Thomassen, A | 1 |
| Höhn, AK; Meyer, HJ; Purz, S; Sabri, O; Surov, A; Wienke, A | 1 |
| Charabi, B; Fischer, BM; Friborg, J; Gram, SB; Håkansson, K; Nøhr, A; Rasmussen, JH; Tvedskov, JF; von Buchwald, C; Wessel, I | 1 |
| Chang, KP; Cheng, NM; Fan, KH; Fan, WL; Fang, KH; Fang, TJ; Hsieh, CH; Hsueh, C; Huang, SF; Kang, CJ; Lee, LA; Lee, LY; Liao, CT; Lin, CH; Lin, CY; Ng, SH; Tsao, CK; Wang, HM; Wang, YC; Yang, LY; Yen, TC | 1 |
| Ahmad, N; Haerle, SK; Hany, TF; Huber, GF; Kastrinidis, N; Kuhn, FP | 1 |
| Cappoen, N; Duprez, T; Gillain, A; Hamoir, M; Hanin, FX; Lhommel, R; Lonneux, M; Machiels, JP; Magremanne, M; Michoux, N; Reychler, H; Rommel, D; Schmitz, S; Weynand, B | 1 |
| Cho, KJ; Joo, YH; Kim, MS; Nam, IC; Park, JO; Yoo, IeR | 2 |
| Agrawal, A; Karapinar, U; Naiboglu, B; Ozer, E; Ozer, HG; Schuller, DE | 1 |
| Adams, G; Burmeister, B; Foote, M; Panizza, B; Porceddu, SV; Pryor, DI; Rowan, A | 1 |
| Cho, KJ; Joo, YH; Kim, CS; Kim, MS; Nam, IC; Park, JO; Yoo, IeR | 1 |
| Hanamoto, A; Hatazawa, J; Inohara, H; Nakahara, S; Shimosegawa, E; Takenaka, Y; Ymamamoto, Y; Yoshii, T | 1 |
| Cho, KJ; Choi, SH; Kim, JS; Kim, JW; Kim, SY; Lee, JH; Nam, SY; Roh, JL | 1 |
| Cervino, AR; Chondrogiannis, S; Colletti, PM; Evangelista, L; Maffione, AM; Marzola, MC; Muzzio, PC; Rubello, D | 1 |
| Fujimoto, Y; Hasegawa, Y; Hiramatsu, M; Itoh, Y; Kato, K; Naganawa, S; Nakashima, T; Suzuki, H | 1 |
| Cooley, T; Mercier, G; Subramaniam, RM; Truong, MT; Yu, J | 1 |
| Borms, M; Cocquyt, V; D'Asseler, Y; Kruse, V; Maes, A; Mees, G; Van De Wiele, C | 1 |
| Beuthien-Baumann, B; Gudziol, V; Kitzler, HH; Kotzerke, J; Laniado, M; Maus, J; Platzek, I; Popp, M; Schneider, M; Schramm, G; van den Hoff, J | 1 |
| Boerhout, EJ; Castelijns, JA; Comans, EF; de Bree, R; de Graaf, P; Hoekstra, OS; Noij, DP; Oprea-Lager, D; Pieters-van den Bos, IC; Reinhard, R | 1 |
| Deasy, JO; Jeong, J; Lee, NY; Oh, JH; Setton, JS | 1 |
| Harada, H; Hino, M; Imai, Y; Itoh, K; Kanazawa, Y; Kikuchi, M; Kishimoto, I; Koyasu, S; Naito, Y; Shinohara, S; Tona, R; Usami, Y | 1 |
| Ciarallo, A; Kang, H; Kiess, AP; Koch, W; Marcus, C; Mena, E; Subramaniam, RM; Tahari, AK; Wahl, RL | 1 |
| Hoermann, K; Klohr, S; Li, CY; Sadick, H; Sadick, M; Schoenberg, SO; Weiss, C | 1 |
| Aznar, MC; Bentzen, SM; Berthelsen, AK; Due, AK; Korreman, SS; Kristensen, CA; Loft, A; Specht, L; Vogelius, IR | 1 |
| Dyrvig, AK; Gerke, O; Godballe, C; Høilund-Carlsen, PF; Johansen, J; Nielsen, AL; Rohde, M; Sørensen, JA | 1 |
| Chen, SW; Chien, CR; Hsieh, TC; Kao, CH; Liang, JA; Wang, YC; Yang, SN; Yen, KY | 1 |
| Adkins, D; Dehdashti, F; Ley, J; Michel, L; Siegel, BA; Siegel, MJ; Trinkaus, K; Wildes, TM | 1 |
| Abgral, R; Keromnes, N; Le Roux, PY; Marianowski, R; Palard, X; Potard, G; Robin, P; Rousset, J; Salaun, PY; Valette, G | 1 |
| Cho, KJ; Joo, YH; Kim, CS; Kim, MS; Kim, SY; Lee, YS; Nam, IC; Park, JO; Yoo, IeR | 1 |
| Alluri, KC; Chung, CH; Koch, W; Subramaniam, RM; Tahari, AK; Wahl, RL | 1 |
| Cheze Le Rest, C; Fayad, H; Fernandez, P; Lamare, F; Le Pogam, A; Pradier, O; Valette, G; Visvikis, D | 1 |
| Ameye, L; Awada, A; Flamen, P; Garcia, C; Lalami, Y; Paesmans, M | 1 |
| Bloemena, E; Boellaard, R; Braakhuis, BJ; Brakenhoff, RH; de Bree, R; Doornaert, PA; Hakim, S; Hoekstra, OS; Leemans, CR; Schouten, CS; Witte, BI | 1 |
| Ishiwata, K; Ito, K; Kubota, K; Minamimoto, R; Miyata, Y; Morooka, M; Okasaki, M; Toyohara, J; Yokoyama, J | 1 |
| Eskola, O; Grénman, R; Grönroos, TJ; Kronqvist, P; Laine, J; Lehtiö, K; Minn, H; Söderström, KO; Solin, O; Viljanen, T | 1 |
| Lauridsen, JK; Rohde, M; Thomassen, A | 1 |
| Aleknavičius, E; Burneckis, A; Daisne, JF; Grybauskas, M | 1 |
| Brandau, S; Franklin, C; Hermann, S; Jure-Kunkel, M; Kerem, A; Lang, S; Öztürk, E; Schäfers, M; Vahle, AK; Wildner, M | 1 |
| Geng, J; Li, X; Nie, F; Zhang, B | 1 |
| Komatsu, M; Mori, M; Nishimura, G; Oridate, N; Taguchi, T; Takahashi, M; Yabuki, K | 1 |
| Kondo, T; Matoba, M; Oota, K; Shimode, Y; Tonami, H; Tuji, H | 2 |
| Barragán, AM; Differding, S; Janssens, G; Lee, JA; Sterpin, E | 1 |
| Besenyi, Z; Csenki, M; Cserháti, A; Dobi, Á; Együd, Z; Gaál, S; Hideghéty, K; Lengyel, Z; Maráz, A; Mózes, P; Pávics, L; Rusz, O; Szántó, E; Varga, Z; Zag, L | 1 |
| Prestwich, RJ; Ramasamy, S; Scarsbrook, AF; Sen, M; Slevin, F; Subesinghe, M | 1 |
| Galoforo, S; Grills, IS; Kane, JL; Krueger, SA; Marples, B; Wilson, GD; Wobb, J | 1 |
| Ishihara, T; Kitajima, K; Kiyota, N; Minamikawa, T; Nibu, K; Otsuki, N; Sasaki, R; Suenaga, Y; Sugimura, K | 1 |
| Hoebers, FJ; Lambin, P; Mottaghy, FM; Öllers, MC; Troost, EG; van Elmpt, W; Zegers, CM | 1 |
| Chang, JT; Cheng, NM; Fang, YH; Lee, LY; Liao, CT; Ng, SH; Tsan, DL; Wang, HM; Yang, LY; Yen, TC | 1 |
| de Bree, R; Hoekstra, OS; Leemans, CR; Senft, A; Witte, BI | 1 |
| Adam, AC; Guntinas-Lichius, O; Huebbers, CU; Klussmann, JP; Preuss, SF; Schiffer, T; Schilder, S; Schmidt, M; Wiesner, RJ | 1 |
| Anwar, B; George, MM; Homer, JJ; Mani, N; Nash, L | 1 |
| Chan, SC; Chang, JT; Fan, KH; Ko, SF; Liao, CT; Lin, CY; Lin, YC; Ng, SH; Wang, HM; Wang, JJ; Yang, LY; Yen, TC | 1 |
| Amegnizin, JL; Durand, P; Kerrou, K; Ohnona, J | 1 |
| Aznar, MC; Bentzen, SM; Fischer, BM; Friborg, J; Håkansson, K; Kristensen, CA; Loft, A; Rasmussen, JH; Specht, L; Vogelius, IR | 1 |
| Agrawal, N; Kang, H; Richmon, J; Sheikhbahaei, S; Subramaniam, RM; Taghipour, M; Wray, R | 1 |
| Cho, KJ; Choi, SH; Kim, JS; Kim, SY; Lee, JH; Nam, SY; Roh, JL; Ryu, IS | 1 |
| Deák, P; Fábián, G; Kahán, Z; Kovács, L; Mózes, P; Nagy, O; Pál, M; Reisz, Z; Rovó, L; Rusz, O; Szilágyi, É; Tiszlavicz, L; Tomisa, B; Varga, Z | 1 |
| Abdulelah, H; Al-Hussaini, M; Al-Ibraheem, A; AlSharif, A | 1 |
| Baek, KH; Cho, JK; Choi, JY; Choi, N; Hyun, SH; Jeong, HS; Kim, MJ; Lee, SH | 1 |
| Ahnesjö, A; Grönlund, E; Johansson, S; Montelius, A | 1 |
| Fujima, N; Hirata, K; Homma, A; Kudo, K; Sakashita, T; Shiga, T; Shirato, H | 1 |
| Alhilahi, LM; Branstetter, BF; Fakhran, S; Hughes, MA; Rath, TJ; Seungwon, KW; Yankevich, U | 1 |
| Appold, S; Bandurska-Luque, A; Baumann, M; Gudziol, V; Haase, R; Kotzerke, J; Krause, M; Leger, S; Löck, S; Richter, C; Schreiber, A; Zips, D; Zöphel, K; Zschaeck, S | 1 |
| Choi, JW; Han, M; Hyun, SH; Kim, JH; Lee, D; Lee, SJ | 1 |
| Cho, KJ; Cho, Y; Choi, SH; Kim, JS; Kim, SB; Kim, SY; Lee, JH; Lee, SW; Nam, SY; Roh, JL; Song, SY; Yoon, DH | 1 |
| Chera, BS; Fried, D; Hackman, T; Hayes, N; Khandani, A; Rosenman, J; Shores, C; Weissler, M | 1 |
| Beaulieu, S; Bélair, M; Boucher, L; Cohade, C; Coulombe, G; Delouya, G; Després, P; Filion, EJ; Hinse, M; Houle, A; Igidbashian, L; Martel, C; Nguyen-Tan, PF | 1 |
| Beswick, DM; Branstetter, BF; Ferris, RL; Gooding, WE; Maxwell, JH; Zhang, I | 1 |
| Akdemir, UO; Baykara, M; Benekli, M; Buyukberber, S; Cakir, T; Coskun, U; Demirci, U; Kapucu, O; Ozkan, S | 1 |
| Agrawal, A; Meacham, R; Naiboğlu, B; Ozer, E; Ryoo, C; Schuller, DE | 1 |
| Codreanu, I; Dasanu, CA; Divgi, C; Weinstein, GS | 1 |
| Ahn, YC; Baek, CH; Choi, JY; Kim, BT; Lee, HJ; Lee, KH; Moon, SH; Park, K; Son, YI | 1 |
| Amin, M; Chunta, JL; Grills, IS; Huang, J; Lee, DY; Marples, B; Martinez, AA; Wilson, GD; Wong, CY; Yan, D | 1 |
| Chera, BS; Cullip, T; Fried, D; Khandani, AH; Lawrence, M; Rosenman, J | 1 |
| Almadori, G; Autorino, R; Bussu, F; Castaldi, P; De Corso, E; Dinapoli, N; Galli, J; Giordano, A; Lago, M; Miccichè, F; Paludetti, G; Rufini, V; Valentini, V | 1 |
| Fukukura, Y; Kajiya, Y; Kamiyama, T; Koriyama, C; Matsuzaki, T; Nakajo, M; Nishimoto, K; Nomoto, M; Tani, A; Yonekura, R | 1 |
| Choi, SH; Kim, JS; Kim, SY; Lee, JH; Nam, SY; Roh, JL; Yi, JS | 1 |
| Monteiro, E; Pereira, G; Silva, JC | 1 |
| Abgral, R; Gouders, D; Keromnes, N; Le Roux, PY; Leleu, C; Mollon, D; Nowak, E; Querellou, S; Rousset, J; Salaün, PY; Valette, G | 1 |
| Burmeister, BH; Porceddu, SV; Pryor, DI; Scuffham, PA; Thomas, PA; Whitty, JA | 1 |
| Caldito, GC; Ekshyyan, O; Nathan, CA; Sibley, D; Sunderland, J; Vascoe, C | 1 |
| Beuthien-Baumann, B; Gudziol, V; Kotzerke, J; Langner, J; Laniado, M; Platzek, I; Schneider, M; Schramm, G; van den Hoff, J | 1 |
| Bogsrud, TV; Eilertsen, K; Evensen, JF; Glomset, OK; Løndalen, AM; Skretting, A | 1 |
19 review(s) available for fluorodeoxyglucose f18 and Squamous Cell Carcinoma of Head and Neck
| Article | Year |
|---|---|
Systematic review and meta-analysis of the diagnostic effectiveness of positron emission tomography-computed tomography versus magnetic resonance imaging in the post-treatment surveillance of head and neck squamous cell carcinoma.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck | 2023 |
Clinical Role of Positron Emission Tomography/Computed Tomography Imaging in Head and Neck Squamous Cell Carcinoma.
Topics: Carcinoma, Squamous Cell; COVID-19; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck | 2022 |
Prognostic value of MTV and TLG of 18 F-FDG PET in patients with head and neck squamous cell carcinoma: A meta-analysis.
Topics: Fluorodeoxyglucose F18; Glycolysis; Head and Neck Neoplasms; Humans; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tumor Burden | 2022 |
Fibroblast Activation Protein Inhibitor PET Imaging in Head and Neck Cancer.
Topics: Carcinoma, Squamous Cell; Female; Fibroblasts; Fluorodeoxyglucose F18; Gallium Radioisotopes; Head and Neck Neoplasms; Humans; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Squamous Cell Carcinoma of Head and Neck; Uterine Cervical Neoplasms | 2023 |
A systematic review and meta-analysis of predictive and prognostic models for outcome prediction using positron emission tomography radiomics in head and neck squamous cell carcinoma patients.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron-Emission Tomography; Prognosis; Reproducibility of Results; Squamous Cell Carcinoma of Head and Neck | 2023 |
Associations between FDG-PET and Ki 67-index in head and neck cancer: A meta-analysis.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Ki-67 Antigen; Positron-Emission Tomography; Squamous Cell Carcinoma of Head and Neck | 2019 |
PET/CT in Surgical Planning for Head and Neck Cancer.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck | 2021 |
18F-FDG PET cannot predict expression of clinically relevant histopathological biomarkers in head and neck squamous cell carcinoma: a meta-analysis.
Topics: Apoptosis; Apoptosis Regulatory Proteins; Biomarkers, Tumor; Cell Proliferation; ErbB Receptors; Fluorodeoxyglucose F18; Genes, p53; Glucose Transporter Type 1; Head and Neck Neoplasms; Humans; Ki-67 Antigen; Microcirculation; Positron-Emission Tomography; Repressor Proteins; Squamous Cell Carcinoma of Head and Neck | 2022 |
Diagnostic Accuracy of Combined PET/CT with MRI, 18F-FDG PET/MRI, and 18F-FDG PET/CT in Patients with Oropharyngeal and Hypopharyngeal Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.
Topics: Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck | 2021 |
Clinical Practice in PET/CT for the Management of Head and Neck Squamous Cell Cancer.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome | 2017 |
Response assessment after induction chemotherapy for head and neck squamous cell carcinoma: From physical examination to modern imaging techniques and beyond.
Topics: Carcinoma, Squamous Cell; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Positron-Emission Tomography; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Treatment Outcome | 2017 |
Detection of Distant Metastases in Head and Neck Cancer: Changing Landscape.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Proteomics; Radiopharmaceuticals; Risk Factors; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Whole Body Imaging | 2018 |
What is the prognostic impact of FDG PET in locally advanced head and neck squamous cell carcinoma treated with concomitant chemo-radiotherapy? A systematic review and meta-analysis.
Topics: Chemoradiotherapy; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Prognosis; Squamous Cell Carcinoma of Head and Neck | 2018 |
Update 2018: 18F-FDG PET/CT and PET/MRI in Head and Neck Cancer.
Topics: Evaluation Studies as Topic; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Randomized Controlled Trials as Topic; Squamous Cell Carcinoma of Head and Neck | 2018 |
Comparison between anatomical cross-sectional imaging and 18F-FDG PET/CT in the staging, restaging, treatment response, and long-term surveillance of squamous cell head and neck cancer: a systematic literature overview.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Staging; Positron-Emission Tomography; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Estimate of the impact of FDG-avidity on the dose required for head and neck radiotherapy local control.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cohort Studies; Dose-Response Relationship, Radiation; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck | 2014 |
18F-fluoro-deoxy-glucose-positron emission tomography/computed tomography in diagnosis of head and neck squamous cell carcinoma: a systematic review and meta-analysis.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2014 |
¹⁸F-fluorodeoxyglucose-positron emission tomography/computed tomography in malignancies of the thyroid and in head and neck squamous cell carcinoma: a review of the literature.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Enhancement; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Thyroid Neoplasms; Tomography, X-Ray Computed | 2015 |
Primary tumor standardized uptake value predicts survival in head and neck squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Incidence; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Survival Analysis | 2015 |
19 trial(s) available for fluorodeoxyglucose f18 and Squamous Cell Carcinoma of Head and Neck
| Article | Year |
|---|---|
Early HPV ctDNA Kinetics and Imaging Biomarkers Predict Therapeutic Response in p16+ Oropharyngeal Squamous Cell Carcinoma.
Topics: Alphapapillomavirus; Biomarkers; Carcinoma, Squamous Cell; Circulating Tumor DNA; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Kinetics; Oropharyngeal Neoplasms; Papillomaviridae; Papillomavirus Infections; Prognosis; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2022 |
Neoadjuvant immunotherapy with nivolumab and ipilimumab induces major pathological responses in patients with head and neck squamous cell carcinoma.
Topics: Aged; Biomarkers, Tumor; Exome Sequencing; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Immune Checkpoint Inhibitors; Immunotherapy; Ipilimumab; Male; Middle Aged; Neoadjuvant Therapy; Nivolumab; Positron-Emission Tomography; Squamous Cell Carcinoma of Head and Neck | 2021 |
Use of Fluoro-[18F]-Deoxy-2-D-Glucose Positron Emission Tomography/Computed Tomography to Predict Immunotherapy Treatment Response in Patients With Squamous Cell Oral Cavity Cancers.
Topics: Carcinoma, Squamous Cell; Epithelial Cells; Fluorodeoxyglucose F18; Glucose; Head and Neck Neoplasms; Humans; Immunotherapy; Mouth Neoplasms; Nivolumab; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2022 |
89Zr-panitumumab Combined With 18F-FDG PET Improves Detection and Staging of Head and Neck Squamous Cell Carcinoma.
Topics: Adult; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Panitumumab; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radioisotopes; Radiopharmaceuticals; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Zirconium | 2022 |
Identifying the location of locoregional recurrences after definitive radiotherapy for head and neck cancer using metabolic parameters of baseline and mid-treatment 18F-FDG-PET scans.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Squamous Cell Carcinoma of Head and Neck | 2023 |
Development and Testing of a Machine Learning Model Using
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Human Papillomavirus Viruses; Humans; Machine Learning; Male; Middle Aged; Oropharyngeal Neoplasms; Papillomavirus Infections; Positron Emission Tomography Computed Tomography; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2023 |
Pre-CCRT 18-fluorodeoxyglucose PET-CT improves survival in patients with advanced stages p16-negative oropharyngeal squamous cell carcinoma via accurate radiation treatment planning.
Topics: Chemoradiotherapy; Fluorodeoxyglucose F18; Humans; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Prospective Studies; Squamous Cell Carcinoma of Head and Neck | 2023 |
Initial Feasibility and Acute Toxicity Outcomes From a Phase 2 Trial of
Topics: Chemoradiotherapy; Feasibility Studies; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prospective Studies; Squamous Cell Carcinoma of Head and Neck | 2023 |
Radiation dose escalation based on FDG-PET driven dose painting by numbers in oropharyngeal squamous cell carcinoma: a dosimetric comparison between TomoTherapy-HA and RapidArc.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Oropharyngeal Neoplasms; Positron-Emission Tomography; Radiometry; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Research Design; Squamous Cell Carcinoma of Head and Neck | 2017 |
Long-term outcome of
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Squamous Cell Carcinoma of Head and Neck; Survival Rate; Treatment Outcome | 2017 |
Activity and safety of afatinib in a window preoperative EORTC study in patients with squamous cell carcinoma of the head and neck (SCCHN).
Topics: Adult; Afatinib; Aged; Antineoplastic Agents; Biomarkers; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Preoperative Care; Squamous Cell Carcinoma of Head and Neck | 2018 |
Early metabolic 18F-FDG PET/CT response of locally advanced squamous-cell carcinoma of head and neck to induction chemotherapy: A prospective pilot study.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Kaplan-Meier Estimate; Male; Middle Aged; Papillomaviridae; Pilot Projects; Positron Emission Tomography Computed Tomography; Progression-Free Survival; Prospective Studies; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome | 2018 |
Dose painting for re-irradiation of head and neck cancer.
Topics: Aged; Aged, 80 and over; Dose Fractionation, Radiation; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Organ Size; Positron-Emission Tomography; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Re-Irradiation; Squamous Cell Carcinoma of Head and Neck; Tumor Burden | 2018 |
Tumour response and safety of cetuximab in a window pre-operative study in patients with squamous cell carcinoma of the head and neck.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Carcinoma, Squamous Cell; Cetuximab; ErbB Receptors; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron-Emission Tomography; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome | 2013 |
A prospective trial comparing FDG-PET/CT and CT to assess tumor response to cetuximab in patients with incurable squamous cell carcinoma of the head and neck.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Carcinoma, Squamous Cell; Cetuximab; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2014 |
Phase II trial evaluating the efficacy of sorafenib (BAY 43-9006) and correlating early fluorodeoxyglucose positron emission tomography-CT response to outcome in patients with recurrent and/or metastatic head and neck cancer.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Niacinamide; Phenylurea Compounds; Positron-Emission Tomography; Sorafenib; Squamous Cell Carcinoma of Head and Neck; Survival Analysis; Treatment Outcome; Young Adult | 2016 |
Lesion regression rate based on RECIST: prediction of treatment outcome in patients with head and neck cancer treated with chemoradiotherapy compared with FDG PET-CT.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Data Interpretation, Statistical; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Regression Analysis; Reproducibility of Results; Response Evaluation Criteria in Solid Tumors; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Phase I trial of 18F-Fludeoxyglucose based radiation dose painting with concomitant cisplatin in head and neck cancer.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Squamous Cell Carcinoma of Head and Neck | 2016 |
Early prediction of survival following induction chemotherapy with DCF (docetaxel, cisplatin, 5-fluorouracil) using FDG PET/CT imaging in patients with locally advanced head and neck squamous cell carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Disease-Free Survival; Docetaxel; Female; Fluorodeoxyglucose F18; Fluorouracil; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Taxoids; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
182 other study(ies) available for fluorodeoxyglucose f18 and Squamous Cell Carcinoma of Head and Neck
| Article | Year |
|---|---|
Correlation between tumor voxel dose response matrix and tumor biomarker profile in patients with head and neck squamous cell carcinoma.
Topics: Biomarkers, Tumor; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron-Emission Tomography; Squamous Cell Carcinoma of Head and Neck | 2021 |
Laterality on FDG-PET/CT in clinically node-negative early-stage oral squamous cell carcinoma: a retrospective analysis of patients with late neck metastasis.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Mouth Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2022 |
PET/CT versus triple endoscopy in initial workup of HPV+ oropharyngeal squamous cell carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Endoscopy; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Oropharyngeal Neoplasms; Papillomavirus Infections; Positron Emission Tomography Computed Tomography; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2022 |
Survival benefit associated with postoperative PET-CT before adjuvant radiotherapy or chemoradiotherapy in patients with oral squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Chemoradiotherapy; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Mouth Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiotherapy, Adjuvant; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2022 |
18F-FDG-PET/CT can be used to predict distant metastasis in hypopharyngeal squamous cell carcinoma.
Topics: Disease-Free Survival; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron Emission Tomography Computed Tomography; Prognosis; Squamous Cell Carcinoma of Head and Neck | 2022 |
Qualitative and quantitative methods in post-chemoradiation PET for head and neck cancer.
Topics: Chemoradiotherapy; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2022 |
Long term survival in patients with human papillomavirus-positive oropharyngeal cancer and equivocal response on 12-week PET-CT is not compromised by the omission of neck dissection.
Topics: Alphapapillomavirus; Carcinoma, Squamous Cell; Chemoradiotherapy; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neck Dissection; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Papillomaviridae; Papillomavirus Infections; Positron Emission Tomography Computed Tomography; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2022 |
Pseudoprogression during Immunotherapy in Metastatic Head and Neck Squamous Cell Carcinoma.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Immunotherapy; Squamous Cell Carcinoma of Head and Neck | 2022 |
Prognostic significance of conventional and volumetric PET parameters with and without partial volume correction in the assessment of head and neck squamous cell carcinoma.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tumor Burden | 2022 |
Histogram analysis of
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Mouth Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck | 2022 |
Comparison of CT, MRI, and F-18 FDG PET/CT for initial N-staging of oral squamous cell carcinoma: a cost-effectiveness analysis.
Topics: Carcinoma, Squamous Cell; Cost-Benefit Analysis; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Mouth Neoplasms; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2022 |
Posttreatment FDG-PET/CT Hopkins criteria predict locoregional recurrence after definitive radiotherapy for oropharyngeal squamous cell carcinoma.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2022 |
Correlation between hematological parameters and PET/CT metabolic parameters in patients with head and neck cancer.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Inflammation; Positron Emission Tomography Computed Tomography; Prognosis; Squamous Cell Carcinoma of Head and Neck; Tumor Microenvironment | 2022 |
Discordance Between Oncology Clinician-Perceived and Radiologist-Intended Meaning of the Postradiotherapy Positron Emission Tomography/Computed Tomography Freeform Report for Head and Neck Cancer.
Topics: Cohort Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiologists; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2022 |
Prognostic Value of
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Human Papillomavirus Viruses; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tumor Burden | 2023 |
The negative predictive value of FDG PET/CT staging in early oropharyngeal squamous cell carcinoma and implications to transoral robotic surgery patient selection.
Topics: Adult; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Staging; Oropharyngeal Neoplasms; Patient Selection; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Retrospective Studies; Robotic Surgical Procedures; Squamous Cell Carcinoma of Head and Neck | 2022 |
Diagnostic efficacy of positron emission computerized tomography scans in suspicious laryngeal findings postorgan preservation treatment.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Larynx; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck | 2023 |
PET/MR versus PET/CT for locoregional staging of oropharyngeal squamous cell cancer.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Neoplasm Staging; Neoplasms, Squamous Cell; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck | 2023 |
Prediction of extranodal extension in oropharyngeal cancer patients and carcinoma of unknown primary: value of metabolic tumor imaging with hybrid PET compared with MRI and CT.
Topics: Extranodal Extension; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Neoplasms, Unknown Primary; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2023 |
Determination of diagnostic and predictive parameters for vertical mandibular invasion in patients with lower gingival squamous cell carcinoma: A retrospective study.
Topics: Fluorodeoxyglucose F18; Gingival Neoplasms; Humans; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Prognosis; Quality of Life; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tumor Burden | 2022 |
Clinical utility of combined assessments of 4D volumetric perfusion CT, diffusion-weighted MRI and
Topics: Carcinoma, Squamous Cell; Chemoradiotherapy; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Four-Dimensional Computed Tomography; Head and Neck Neoplasms; Humans; Perfusion; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck | 2023 |
Diagnostic Performance of Response Assessment FDG-PET/CECT in HNSCC Treated With Definitive Radio(chemo)therapy Using NI-RADS.
Topics: Adult; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2023 |
A prediction model of nodal metastasis in cN0 oral squamous cell carcinoma using metabolic and pathological variables.
Topics: Carcinoma, Squamous Cell; China; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Mouth Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2023 |
Prognostic value of initial [ 18 F]FDG PET/computed tomography volumetric and texture analysis-based parameters in patients with head and neck squamous cell carcinoma.
Topics: Adult; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Tumor Burden | 2023 |
Volume-based 18F-fluorodeoxyglucose positron emission tomography/computed tomography parameters correlate with delayed neck metastasis in clinical early-stage oral squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Mouth Neoplasms; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2023 |
Post-operative PET/CT improves the detection of early recurrence of squamous cell carcinomas of the oral cavity.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Mouth Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2023 |
Role of 18F-FDG PET/CT in evaluating lymph node status in patients with head and neck squamous cell carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck | 2023 |
Obstructive Sialadenitis from Oral Squamous Cell Carcinoma: [
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Gallium Radioisotopes; Head and Neck Neoplasms; Humans; Mouth Neoplasms; Positron Emission Tomography Computed Tomography; Quinolines; Sialadenitis; Squamous Cell Carcinoma of Head and Neck | 2023 |
Diagnostic performance of FDG PET/MRI for cervical lymph node metastasis in patients with clinically N0 head and neck cancer.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck | 2023 |
Association Between 18F-Fluorodeoxyglucose Uptake and Mutation Status of Epidermal Growth Factor Receptor in Sinonasal Tract Cancer.
Topics: Carcinoma, Squamous Cell; ErbB Receptors; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Mutation; Paranasal Sinuses; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck | 2023 |
Classification of head and neck cancer from PET images using convolutional neural networks.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neural Networks, Computer; Positron-Emission Tomography; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2023 |
A comparison of loco-regional relapse pattern in HPV positive vs negative oropharyngeal cancers following radiotherapy; relation to pretreatment FDG-PET and radiotherapy target volumes.
Topics: Chronic Disease; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Oropharyngeal Neoplasms; Papillomavirus Infections; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Squamous Cell Carcinoma of Head and Neck | 2023 |
Prognostic significance of the harmonized maximum standardized uptake value of 18F-FDG-PET/CT in patients with resectable oral tongue squamous cell carcinoma: a multicenter study.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tongue Neoplasms | 2023 |
An Intensive 18F-Fludeoxyglucose-Positron Emission Tomography With Computed Tomography-Based Strategy of Follow-Up in Patients Treated for Head and Neck Squamous Cell Carcinoma Who Are Clinically Asymptomatic.
Topics: Adult; Case-Control Studies; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Squamous Cell Carcinoma of Head and Neck | 2023 |
The Effects of Human Papillomavirus Status and Treatment on the Positive Predictive Value of Post-radiotherapy
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Human Papillomavirus Viruses; Humans; Papillomavirus Infections; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2023 |
Contribution of FDG-PET in the diagnostic assessment of cervical lymph node metastasis in Oral Cavity Squamous Cell Carcinoma (OCSCC).
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Mouth Neoplasms; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2023 |
Topics: Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Proportional Hazards Models; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Survival Rate | 2020 |
Second-look PET-CT following an initial incomplete PET-CT response to (chemo)radiotherapy for head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck | 2020 |
Evaluation of quantitative imaging parameters in head and neck squamous cell carcinoma.
Topics: Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypoxia; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Tumor Burden | 2022 |
Detection of Recurrence in Retromolar Trigone using "Puffed Cheek" F-18 FDG PET-CT Scan.
Topics: Cheek; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Mouth Neoplasms; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Tongue Neoplasms | 2019 |
High nodal FDG uptake increases risk of distant metastasis in patients with oropharyngeal squamous cell carcinoma.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2020 |
Correlation Between Semiquantitative Metabolic Parameters After PET/CT and Histologic Prognostic Factors in Laryngeal and Pharyngeal Carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Male; Middle Aged; Pharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2020 |
The importance of FDG-PET/CT parameters for the assessment of the immune status in advanced HNSCC.
Topics: Aged; Aged, 80 and over; Antigens, CD; Antigens, Differentiation, Myelomonocytic; C-Reactive Protein; Female; Fluorodeoxyglucose F18; Glycolysis; Head and Neck Neoplasms; Humans; Inflammation; Lactic Acid; Leukocyte Count; Lymphocyte Count; Macrophages; Male; Middle Aged; Monocytes; Neutrophils; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Receptors, Cell Surface; Squamous Cell Carcinoma of Head and Neck | 2020 |
Correlation between histogram-based DCE-MRI parameters and 18F-FDG PET values in oropharyngeal squamous cell carcinoma: Evaluation in primary tumors and metastatic nodes.
Topics: Aged; Cohort Studies; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Magnetic Resonance Imaging; Male; Middle Aged; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Tumor Burden | 2020 |
Post-treatment FDG PET-CT in head and neck carcinoma: comparative analysis of 4 qualitative interpretative criteria in a large patient cohort.
Topics: Adult; Aged; Aged, 80 and over; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Survival Rate; Young Adult | 2020 |
Application of integrated positron emission tomography/magnetic resonance imaging in evaluating the prognostic factors of head and neck squamous cell carcinoma with positron emission tomography, diffusion-weighted imaging, dynamic contrast enhancement and
Topics: Carcinoma, Squamous Cell; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck | 2020 |
Diagnostic Value of FDG-PET/CT for the Identification of Extranodal Extension in Patients With Head and Neck Squamous Cell Carcinoma.
Topics: Adult; Aged; Extranodal Extension; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck | 2020 |
The Diagnostic Capacity of Pre-treatment 18F-FDG PET/CT for Predicting the Extranodular Spread of Lymph Node Metastases in Patients with Oral Squamous Cell Carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Squamous Cell Carcinoma of Head and Neck | 2020 |
Single-Center Prospective Trial Investigating the Feasibility of Serial FDG-PET Guided Adaptive Radiation Therapy for Head and Neck Cancer.
Topics: Aged; Feasibility Studies; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Middle Aged; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Image-Guided; Radiotherapy, Intensity-Modulated; Squamous Cell Carcinoma of Head and Neck | 2020 |
Multiple synchronous squamous cell carcinomas of the head and neck: A case report.
Topics: Adult; Biopsy; Disease Management; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Lymph Nodes; Male; Neoplasms, Multiple Primary; Positron Emission Tomography Computed Tomography; Squamous Cell Carcinoma of Head and Neck | 2020 |
Topics: Adult; Aged; Aged, 80 and over; Chemoradiotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Genetic Testing; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm, Residual; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2020 |
Does multiparametric imaging with
Topics: Aged; B7-H1 Antigen; Biomarkers, Tumor; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Male; Middle Aged; Multiparametric Magnetic Resonance Imaging; Positron-Emission Tomography; Prospective Studies; Squamous Cell Carcinoma of Head and Neck | 2020 |
Primary vs nodal site PET/CT response as a prognostic marker in oropharyngeal squamous cell carcinoma treated with intensity-modulated radiation therapy.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Middle Aged; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2020 |
Analyzing oropharyngeal cancer survival outcomes: a decision tree approach.
Topics: Adult; Aged; Aged, 80 and over; Decision Trees; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Middle Aged; Oropharyngeal Neoplasms; Papillomavirus Infections; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome | 2020 |
Positive Predictive Value of Neck Imaging Reporting and Data System Categories 3 and 4 Posttreatment FDG-PET/CT in Head and Neck Squamous Cell Carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Treatment Failure | 2020 |
Deep learning analysis using FDG-PET to predict treatment outcome in patients with oral cavity squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Deep Learning; Diagnosis, Computer-Assisted; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome; Tumor Burden | 2020 |
Positron Emission Tomography-Computed Tomography Surveillance after (Chemo)Radiotherapy in Advanced Head and Neck Squamous Cell Cancer: Beyond the PET-NECK Protocol.
Topics: Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Survival Rate | 2020 |
Prospective evaluation of the impact of human papilloma virus status and small node size on the diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography/computed tomography for primary head and neck squamous cell carcinoma.
Topics: Alphapapillomavirus; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Papillomaviridae; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck | 2020 |
Adherence to pretreatment and intratreatment imaging of head and neck squamous cell carcinoma patients undergoing (chemo) radiotherapy in a research setting.
Topics: Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck | 2021 |
Prediction of survival outcome based on clinical features and pretreatment
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck | 2020 |
Response evaluation of cervical lymph nodes after chemoradiation in patients with head and neck cancer - does additional [18F]FDG-PET-CT help?
Topics: Adult; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck | 2020 |
Predictive value of suvmax changes between two sequential post-therapeutic FDG-pet in head and neck squamous cell carcinomas.
Topics: Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2020 |
CT and FDG-PET radiologic biomarkers in p16+ oropharyngeal squamous cell carcinoma patients treated with definitive chemoradiotherapy.
Topics: Biomarkers; Carcinoma, Squamous Cell; Chemoradiotherapy; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2021 |
Comparative effectiveness of posttreatment imaging modalities for Medicare patients with advanced head and neck cancer.
Topics: Aged; Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Larynx; Male; Medicare; Middle Aged; Mouth; Neoplasm Recurrence, Local; Oropharynx; Positron-Emission Tomography; Squamous Cell Carcinoma of Head and Neck; United States | 2021 |
Impact of 18F-2-fluoro-2-deoxy-D-glucose PET/computerized tomography on the initial staging and changing the management intent in head and neck squamous cell carcinoma.
Topics: Adult; Clinical Decision-Making; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Squamous Cell Carcinoma of Head and Neck | 2021 |
Response Evaluation Criteria in Solid Tumors (RECIST) and PET Response Criteria in Solid Tumors (PERCIST) for response evaluation of the neck after chemoradiotherapy in head and neck squamous cell carcinoma.
Topics: Chemoradiotherapy; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Response Evaluation Criteria in Solid Tumors; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2021 |
Texture Analysis Using Preoperative Positron Emission Tomography Images May Predict the Prognosis of Patients With Resectable Oral Squamous Cell Carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Mouth Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2021 |
PET-CT scan-based maximum standardized uptake value as a prognostic predictor in oropharynx squamous cell cancer.
Topics: Adult; Aged; Chemoradiotherapy; Disease-Free Survival; Feasibility Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Risk Assessment; Squamous Cell Carcinoma of Head and Neck; Tissue Distribution | 2021 |
Prognostic value of tumor metabolic imaging phenotype by FDG PET radiomics in HNSCC.
Topics: Adult; Aged; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Phenotype; Positron-Emission Tomography; Prognosis; Squamous Cell Carcinoma of Head and Neck | 2021 |
Prognostic value of 18F-FDG PET/MRI in patients with advanced oropharyngeal and hypopharyngeal squamous cell carcinoma.
Topics: Aged; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Survival Analysis; Tumor Burden | 2021 |
F-18 FDG PET-CT for response evaluation in head and neck malignancy: Experience from a tertiary level hospital in south India.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Feasibility Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; India; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tertiary Care Centers; Treatment Outcome; Young Adult | 2021 |
FDG-PET-CT/MRI in head and neck squamous cell carcinoma: Impact on pretherapeutic N classification, detection of distant metastases, and second primary tumors.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck | 2021 |
Intratumor heterogeneity is biomarker specific and challenges the association with heterogeneity in multimodal functional imaging in head and neck squamous cell carcinoma.
Topics: Biomarkers; Biomarkers, Tumor; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Squamous Cell Carcinoma of Head and Neck | 2021 |
Accuracy of 18-F Fluorodeoxyglucose Positron Emission Tomographic/Computed Tomographic Imaging in Primary Staging of Squamous Cell Carcinoma of the Oral Cavity.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mouth; Mouth Neoplasms; Neck; Neck Dissection; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Young Adult | 2021 |
The Utility of Ultrasonography in the Diagnosis of Cervical Lymph Nodes after Chemoradiotherapy for Head and Neck Squamous Cell Carcinoma.
Topics: Carcinoma, Squamous Cell; Chemoradiotherapy; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Ultrasonography | 2021 |
Prediction of the treatment outcome using machine learning with FDG-PET image-based multiparametric approach in patients with oral cavity squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Machine Learning; Male; Middle Aged; Mouth; Mouth Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome | 2021 |
Deep Learning for Fully Automated Prediction of Overall Survival in Patients with Oropharyngeal Cancer Using FDG-PET Imaging.
Topics: Cohort Studies; Deep Learning; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Oropharyngeal Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Survival Rate | 2021 |
FDG-PET/CT identified distant metastases and synchronous cancer in squamous cell carcinoma of the head and neck: the impact of smoking and P16-s.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Oropharyngeal Neoplasms; Papillomavirus Infections; Positron Emission Tomography Computed Tomography; Retrospective Studies; Smoking; Squamous Cell Carcinoma of Head and Neck | 2022 |
Correlation between 18F-FDG PET/CT and diffusion-weighted MRI parameters in head and neck squamous cell carcinoma at baseline and after chemo-radiotherapy. A retrospective single institutional study.
Topics: Chemoradiotherapy; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Glucose; Head and Neck Neoplasms; Humans; Positron Emission Tomography Computed Tomography; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2022 |
Beyond the
Topics: Carcinoma, Squamous Cell; Electrons; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Mouth Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Squamous Cell Carcinoma of Head and Neck | 2022 |
The ability of post-chemoradiotherapy DWI ADC
Topics: Aged; Cell Transformation, Viral; Chemoradiotherapy; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Papillomaviridae; Papillomavirus Infections; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Prospective Studies; Squamous Cell Carcinoma of Head and Neck; Time Factors; Treatment Outcome | 2021 |
Comparison of different diagnostic imaging techniques for the detection of bone invasion in oral cancers.
Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Mandible; Mouth Neoplasms; Neoplasm Invasiveness; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2021 |
FDG-PET predicts bone invasion and prognosis in patients with oral squamous cell carcinoma.
Topics: Adult; Aged; Bone Neoplasms; Cohort Studies; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Mouth Neoplasms; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Taiwan | 2021 |
Prediction of the local treatment outcome in patients with oropharyngeal squamous cell carcinoma using deep learning analysis of pretreatment FDG-PET images.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Clinical Decision-Making; Combined Modality Therapy; Deep Learning; Disease Management; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Staging; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; ROC Curve; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome; Workflow | 2021 |
Mid-treatment Fluorodeoxyglucose Positron Emission Tomography in Human Papillomavirus-related Oropharyngeal Squamous Cell Carcinoma Treated with Primary Radiotherapy: Nodal Metabolic Response Rate can Predict Treatment Outcomes.
Topics: Alphapapillomavirus; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome | 2021 |
Value of [18F]FDG PET-CT in the follow-up of surgically treated oral tongue squamous cell carcinoma: single centre cohort analysis on 87 patients.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Tongue Neoplasms | 2021 |
Preoperative
Topics: Carcinoma, Squamous Cell; Contrast Media; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Preoperative Care; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2017 |
18F-FDG-PET/CT for the detection of disease in patients with head and neck cancer treated with radiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Neoplasm, Residual; Positron Emission Tomography Computed Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck | 2017 |
Local recurrence of squamous cell carcinoma of the head and neck after radio(chemo)therapy: Diagnostic performance of FDG-PET/MRI with diffusion-weighted sequences.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck | 2018 |
Differential Prognostic Value of Metabolic Heterogeneity of Primary Tumor and Metastatic Lymph Nodes in Patients with Pharyngeal Cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glycolysis; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Pharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Time Factors; Treatment Outcome; Young Adult | 2017 |
Post-radiochemotherapy PET radiomics in head and neck cancer - The influence of radiomics implementation on the reproducibility of local control tumor models.
Topics: Carcinoma, Squamous Cell; Chemoradiotherapy; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Prognosis; Reproducibility of Results; Squamous Cell Carcinoma of Head and Neck | 2017 |
Associations of Tumor PD-1 Ligands, Immunohistochemical Studies, and Textural Features in
Topics: B7-H1 Antigen; Biomarkers, Tumor; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Male; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Programmed Cell Death 1 Receptor; Reproducibility of Results; ROC Curve; Squamous Cell Carcinoma of Head and Neck | 2018 |
Accuracy of FDG PET-CT response assessment following radiotherapy alone for head and neck squamous cell carcinoma: Retrospective analysis of 45 patients.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome | 2018 |
Clinical value of
Topics: Adult; Aged; Aged, 80 and over; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Survival Rate | 2018 |
Adaptive Boost Target Definition in High-Risk Head and Neck Cancer Based on Multi-imaging Risk Biomarkers.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Blood Volume; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Squamous Cell Carcinoma of Head and Neck; Tumor Burden | 2018 |
Images in Vascular Medicine: Septic and tumor thrombosis caught by inferior vena cava filters and demonstrated on FDG PET/CT.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Neoplastic Cells, Circulating; Nose Neoplasms; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prosthesis Implantation; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Squamous Cell Carcinoma of Head and Neck; Vena Cava Filters; Venous Thrombosis | 2018 |
Assessment of tumor response to chemoradiotherapy and predicting prognosis in patients with head and neck squamous cell carcinoma by PERCIST.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Young Adult | 2018 |
Contrast-enhanced 18F-FDG-PET/CT for Differentiating Tumour and Radionecrosis in Head and Neck Cancer: Our experience in 37 Patients.
Topics: Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Mandible; Middle Aged; Osteoradionecrosis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Radiotherapy, Adjuvant; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2018 |
Tumor to cervical spinal cord standardized uptake ratio (SUR) improves the reproducibility of
Topics: Adult; Aged; Cervical Cord; Cohort Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Regression Analysis; Reproducibility of Results; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tumor Burden | 2019 |
Negative Predictive Value of NI-RADS Category 2 in the First Posttreatment FDG-PET/CT in Head and Neck Squamous Cell Carcinoma.
Topics: Adult; Aged; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Treatment Failure | 2018 |
Relationships between histogram analysis of ADC values and complex 18F-FDG-PET parameters in head and neck squamous cell carcinoma.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck | 2018 |
Palatine tonsil SUVmax on FDG PET-CT as a discriminator between benign and malignant tonsils in patients with and without head and neck squamous cell carcinoma of unknown primary.
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Palatine Tonsil; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck | 2019 |
Prediction of ultrasound guided fine needle aspiration cytology results by FDG PET-CT for lymph node metastases in head and neck squamous cell carcinoma patients.
Topics: Adult; Cytodiagnosis; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Retrospective Studies; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck | 2018 |
Prognostic value of textural indices extracted from pretherapeutic 18-F FDG-PET/CT in head and neck squamous cell carcinoma.
Topics: Aged; Cohort Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Tumor Burden | 2019 |
Post-radiotherapy PET/CT for predicting treatment outcomes in head and neck cancer after postoperative radiotherapy.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Postoperative Period; Prognathism; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome | 2019 |
Prospective comparative study of MRI including diffusion-weighted images versus FDG PET-CT for the detection of recurrent head and neck squamous cell carcinomas after (chemo)radiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Chemoradiotherapy; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prospective Studies; Squamous Cell Carcinoma of Head and Neck | 2019 |
Clinical Utility of Pretreatment and 3-Month
Topics: Adult; Aged; Antineoplastic Agents; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2019 |
The prognostic significance of intratumoral heterogeneity of 18F-FDG uptake in patients with oral cavity squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mouth Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2019 |
Positron Emission Tomography/Computed Tomography in Evaluation of the Clinically N0 Neck in Head and Neck Squamous Cell Carcinoma.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron Emission Tomography Computed Tomography; Squamous Cell Carcinoma of Head and Neck | 2019 |
Upfront PET/CT affects management decisions in patients with recurrent head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Clinical Decision-Making; Disease Management; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Interdisciplinary Communication; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prospective Studies; Squamous Cell Carcinoma of Head and Neck | 2019 |
Combined parameter SUVmax/ADCmean predicts microvessel density in head and neck squamous cell carcinoma. Preliminary results.
Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Microvessels; Multimodal Imaging; Neovascularization, Pathologic; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; ROC Curve; Squamous Cell Carcinoma of Head and Neck | 2020 |
PET/CT prior to salvage surgery in recurrent head and neck squamous cell carcinoma.
Topics: Antineoplastic Protocols; Bone Neoplasms; Denmark; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Salvage Therapy; Squamous Cell Carcinoma of Head and Neck; Survival Analysis | 2019 |
A combined analysis of maximum standardized uptake value on FDG-PET, genetic markers, and clinicopathological risk factors in the prognostic stratification of patients with resected oral cavity squamous cell carcinoma.
Topics: Fluorodeoxyglucose F18; Genetic Markers; Humans; Lymph Nodes; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Squamous Cell Carcinoma of Head and Neck | 2020 |
18F-FDG-PET/CT for the assessment of the contralateral neck in patients with head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2013 |
Preoperative 18F-FDG PET/CT and high-risk HPV in patients with oropharyngeal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Alphapapillomavirus; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Human papillomavirus 16; Humans; In Situ Hybridization; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Middle Aged; Oropharyngeal Neoplasms; Papillomavirus Infections; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Tongue Neoplasms; Tonsillar Neoplasms | 2014 |
Clinicopathological determinants of positron emission tomography computed tomography fluorodeoxyglucose standardised uptake value in head and neck carcinoma.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck | 2013 |
Outcomes after primary chemoradiotherapy for N3 (>6 cm) head and neck squamous cell carcinoma after an FDG-PET--guided neck management policy.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck; Neck Dissection; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome | 2014 |
Standardized uptake value and resection margin involvement predict outcomes in pN0 head and neck cancer.
Topics: Adult; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Republic of Korea; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Survival Rate; Time Factors | 2013 |
Prognostic value of preoperative 18F-FDG PET/CT for primary head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cohort Studies; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Lymph Nodes; Male; Middle Aged; Mouth Neoplasms; Multimodal Imaging; Multivariate Analysis; Neck; Pharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Young Adult | 2014 |
Limitation of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography (FDG-PET) to detect early synchronous primary cancers in patients with untreated head and neck squamous cell cancer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms, Multiple Primary; Positron-Emission Tomography; Squamous Cell Carcinoma of Head and Neck; Young Adult | 2013 |
(18)F-FDG PET/CT surveillance at 3-6 and 12 months for detection of recurrence and second primary cancer in patients with head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Young Adult | 2013 |
Prognostic value of (18)F-fluorodeoxyglucose uptake before treatment for pharyngeal cancer.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Pharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Survival Analysis; Survival Rate; Tomography, X-Ray Computed | 2014 |
Head and neck squamous cell cancer (stages III and IV) induction chemotherapy assessment: value of FDG volumetric imaging parameters.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Computer Simulation; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Induction Chemotherapy; Male; Middle Aged; Models, Biological; Neoplasm Staging; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome; Tumor Burden | 2014 |
Reproducibility of FDG PET based metabolic tumor volume measurements and of their FDG distribution within.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Reproducibility of Results; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tumor Burden | 2015 |
FDG PET/MR for lymph node staging in head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck | 2014 |
Whole-body-MR imaging including DWIBS in the work-up of patients with head and neck squamous cell carcinoma: a feasibility study.
Topics: Aged; Carcinoma, Squamous Cell; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Whole Body Imaging | 2014 |
Prognostic value of pretreatment 18F-fluorodeoxyglucose positron emission tomography/CT volume-based parameters in patients with oropharyngeal squamous cell carcinoma with known p16 and p53 status.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Cone-Beam Computed Tomography; Cyclin-Dependent Kinase Inhibitor p16; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Proteins; Neoplasm Staging; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Survival Rate; Tomography, X-Ray Computed; Tumor Suppressor Protein p53 | 2015 |
Head and neck PET/CT: therapy response interpretation criteria (Hopkins Criteria)-interreader reliability, accuracy, and survival outcomes.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Proportional Hazards Models; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Effect of time-of-flight technique on the diagnostic performance of 18F-FDG PET/CT for assessment of lymph node metastases in head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2014 |
Recurrences after intensity modulated radiotherapy for head and neck squamous cell carcinoma more likely to originate from regions with high baseline [18F]-FDG uptake.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2014 |
Interim FDG PET/CT for predicting the outcome in patients with head and neck cancer.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Disease-Free Survival; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; ROC Curve; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2014 |
Diagnostic performance of FDG PET/CT to detect subclinical HNSCC recurrence 6 months after the end of treatment.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2015 |
Association between the standardized uptake value and high-risk HPV in hypopharyngeal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cohort Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Papillomavirus Infections; Positron-Emission Tomography; Preoperative Care; Proportional Hazards Models; Retrospective Studies; Risk Assessment; ROC Curve; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Survival Analysis | 2014 |
Prognostic value of FDG PET metabolic tumor volume in human papillomavirus-positive stage III and IV oropharyngeal squamous cell carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Oropharyngeal Neoplasms; Papillomaviridae; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Survival Rate; Tumor Burden | 2014 |
Influence of partial volume correction in staging of head and neck squamous cell carcinoma using PET/CT.
Topics: Aged; Algorithms; Artifacts; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Tumor Burden | 2014 |
Interaction of quantitative (18)F-FDG-PET-CT imaging parameters and human papillomavirus status in oropharyngeal squamous cell carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Immunohistochemistry; Male; Middle Aged; Oropharyngeal Neoplasms; Papillomaviridae; Papillomavirus Infections; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2016 |
Volumetric comparison of positron emission tomography/computed tomography using 4'-[methyl-¹¹C]-thiothymidine with 2-deoxy-2-¹⁸F-fluoro-D-glucose in patients with advanced head and neck squamous cell carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Ki-67 Antigen; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Recurrence; Squamous Cell Carcinoma of Head and Neck; Thionucleosides; Thymidine; Tomography, X-Ray Computed; Tumor Burden | 2015 |
Hypoxia, blood flow and metabolism in squamous-cell carcinoma of the head and neck: correlations between multiple immunohistochemical parameters and PET.
Topics: Biomarkers; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypoxia; Immunohistochemistry; Neoplasm Grading; Neoplasm Staging; Neovascularization, Pathologic; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome; Tumor Burden | 2014 |
Early prediction of response to cetuximab and radiotherapy by FDG-PET/CT for the treatment of a locoregionally advanced squamous cell carcinoma of the hypopharynx.
Topics: Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Cetuximab; Chemoradiotherapy; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome | 2014 |
Multimodal imaging analysis of an orthotopic head and neck cancer mouse model and application of anti-CD137 tumor immune therapy.
Topics: 4-1BB Ligand; Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Immunohistochemistry; Immunotherapy; Longitudinal Studies; Magnetic Resonance Imaging; Mice; Mice, Inbred C3H; Mouth Neoplasms; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Squamous Cell Carcinoma of Head and Neck | 2016 |
Long-term results of survival analysis after a 5-year follow-up: Efficacy of fluoro-2-deoxy-D-glucose positron emission tomography to evaluate responses to concurrent chemoradiotherapy for head and neck squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Chemoradiotherapy; Disease-Free Survival; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome | 2015 |
Feasibility and robustness of dose painting by numbers in proton therapy with contour-driven plan optimization.
Topics: Carcinoma, Squamous Cell; Feasibility Studies; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Organs at Risk; Oropharyngeal Neoplasms; Pattern Recognition, Automated; Positron-Emission Tomography; Proton Therapy; Protons; Radiometry; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Squamous Cell Carcinoma of Head and Neck; Time Factors; Tomography, X-Ray Computed | 2015 |
[Role of 18FDG-PET/CT in the management and gross tumor volume definition for radiotherapy of head and neck cancer; single institution experiences based on long-term follow-up].
Topics: Adult; Aged; Aged, 80 and over; Cancer Care Facilities; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Hungary; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2015 |
Assessment of outcomes with delayed (18)F-FDG PET-CT response assessment in head and neck squamous cell carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
The Effects of Pulsed Radiation Therapy on Tumor Oxygenation in 2 Murine Models of Head and Neck Squamous Cell Carcinoma.
Topics: Animals; Carcinoma, Squamous Cell; Cell Hypoxia; Coloring Agents; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Heterografts; Mice; Mice, Nude; Misonidazole; Neoplasm Recurrence, Local; Nitroimidazoles; Oxygen Consumption; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Tumor Burden | 2015 |
FDG-PET/contrast-enhanced CT as a post-treatment tool in head and neck squamous cell carcinoma: comparison with FDG-PET/non-contrast-enhanced CT and contrast-enhanced CT.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Contrast Media; Face; Female; Fluorodeoxyglucose F18; Head; Head and Neck Neoplasms; Humans; Image Enhancement; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2016 |
Imaging of tumour hypoxia and metabolism in patients with head and neck squamous cell carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypoxia; Image Interpretation, Computer-Assisted; Imidazoles; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Triazoles | 2015 |
Heterogeneity of (18)F-FDG PET combined with expression of EGFR may improve the prognostic stratification of advanced oropharyngeal carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; ErbB Receptors; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Squamous Cell Carcinoma of Head and Neck | 2016 |
Screening for distant metastases in head and neck cancer patients using FDG-PET and chest CT: validation of an algorithm.
Topics: Adult; Aged; Algorithms; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2016 |
High glucose uptake unexpectedly is accompanied by high levels of the mitochondrial ß-F1-ATPase subunit in head and neck squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Glucose; Head and Neck Neoplasms; Humans; Male; Middle Aged; Mitochondria; Mitochondrial Proton-Translocating ATPases; Positron-Emission Tomography; Squamous Cell Carcinoma of Head and Neck | 2015 |
Role of 18-Fludeoxyglucose positron emission tomography-computed tomography and subsequent panendoscopy in head and neck squamous cell carcinoma of unknown primary.
Topics: Carcinoma, Squamous Cell; Endoscopy; False Positive Reactions; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Tongue Neoplasms | 2016 |
Dynamic contrast-enhanced MRI, diffusion-weighted MRI and
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Diffusion Magnetic Resonance Imaging; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Male; Middle Aged; Multimodal Imaging; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck | 2016 |
Silicone Granuloma in the Buttocks Incidentally Detected by 18F-FDG PET/CT 30 Years After Free Liquid Silicone Injections.
Topics: Buttocks; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Granuloma; Head and Neck Neoplasms; Humans; Incidental Findings; Injections, Intramuscular; Laryngeal Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Silicones; Squamous Cell Carcinoma of Head and Neck; Transgender Persons | 2016 |
FDG PET/CT in Patients With Head and Neck Squamous Cell Carcinoma After Primary Surgical Resection With or Without Chemoradiation Therapy.
Topics: Aged; Carcinoma, Squamous Cell; Chemoradiotherapy, Adjuvant; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2016 |
Impact of (18)F-FDG PET/CT staging on management and prognostic stratification in head and neck squamous cell carcinoma: A prospective observational study.
Topics: Aged; Carcinoma, Squamous Cell; Disease Progression; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck | 2016 |
The Expression of Checkpoint and DNA Repair Genes in Head and Neck Cancer as Possible Predictive Factors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; DNA Damage; DNA Repair; Docetaxel; Down-Regulation; Female; Fluorodeoxyglucose F18; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Radiotherapy Dosage; Squamous Cell Carcinoma of Head and Neck; Taxoids; Up-Regulation | 2017 |
Synchronous presentation of nasopharyngeal carcinoma and abdominal paraganglioma with avid 18F-FDG and 68Ga-DOTA-TOC uptake in PET/CT by both tumours.
Topics: Abdominal Neoplasms; Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasms, Multiple Primary; Organometallic Compounds; Paraganglioma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Tissue Distribution | 2016 |
Prognostic significance of clinical and
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Survival Analysis; Young Adult | 2016 |
Dose painting by numbers based on retrospectively determined recurrence probabilities.
Topics: Adult; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Probability; Radiotherapy Dosage; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Tumor Burden | 2017 |
Glucose Metabolism and Its Complicated Relationship with Tumor Growth and Perfusion in Head and Neck Squamous Cell Carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cell Proliferation; Female; Fluorodeoxyglucose F18; Glucose; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Perfusion; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Spin Labels; Squamous Cell Carcinoma of Head and Neck | 2016 |
The role of changes in maximum standardized uptake value of FDG PET-CT for post-treatment surveillance in patients with head and neck squamous cell carcinoma treated with chemoradiotherapy: preliminary findings.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome | 2017 |
PET/CT for Head and Neck Squamous Cell Carcinoma: Should We Routinely Include the Head and Abdomen?
Topics: Abdominal Neoplasms; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Middle Aged; Pennsylvania; Positron Emission Tomography Computed Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Skull Neoplasms; Squamous Cell Carcinoma of Head and Neck | 2017 |
FDG uptake in normal tissues assessed by PET during treatment has prognostic value for treatment results in head and neck squamous cell carcinomas undergoing radiochemotherapy.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2017 |
Intratumoural heterogeneity measured using FDG PET and MRI is associated with tumour-stroma ratio and clinical outcome in head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2017 |
Usefulness of interim FDG-PET after induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck receiving sequential induction chemotherapy followed by concurrent chemoradiotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Drug Combinations; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms, Squamous Cell; Oxonic Acid; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Conformal; Remission Induction; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tegafur; Treatment Outcome | 2011 |
Matched cohort analysis of the effect of pretreatment positron emission tomography on clinical outcomes of patients with head and neck cancer treated with definitive chemoradiotherapy.
Topics: Carcinoma, Squamous Cell; Chemoradiotherapy; Cohort Studies; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Survival Rate; Treatment Outcome | 2012 |
¹⁸F-FDG-PET imaging in radiotherapy tumor volume delineation in treatment of head and neck cancer.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Image-Guided; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2011 |
The benefit of early PET/CT surveillance in HPV-associated head and neck squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Diagnosis, Differential; Disease-Free Survival; DNA, Viral; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Human papillomavirus 16; Humans; In Situ Hybridization; Incidence; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Papillomavirus Infections; Pennsylvania; Population Surveillance; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Survival Rate; Tomography, X-Ray Computed | 2011 |
The nodal standard uptake value (SUV) as a prognostic factor in head and neck squamous cell cancer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2011 |
The value of PET/CT to assess clinically negative necks.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Multimodal Imaging; Neck; Neck Dissection; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2012 |
Fluorodeoxyglucose-induced allergic reaction: a case report.
Topics: Anti-Allergic Agents; Anti-Inflammatory Agents; Carcinoma, Squamous Cell; Diphenhydramine; Drug Hypersensitivity; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prednisone; Pyriform Sinus; Radiopharmaceuticals; Secondary Prevention; Squamous Cell Carcinoma of Head and Neck; Terfenadine; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Prognostic value of 18F-FDG PET/CT in patients with squamous cell carcinoma of the tonsil: comparisons of volume-based metabolic parameters.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Palatine Tonsil; Positron-Emission Tomography; Prognosis; Squamous Cell Carcinoma of Head and Neck; Survival Analysis; Tomography, X-Ray Computed; Tonsillar Neoplasms | 2013 |
Detailed characterization of the early response of head-neck cancer xenografts to irradiation using (18)F-FDG-PET imaging.
Topics: Animals; Area Under Curve; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Mice; Mice, Nude; Multimodal Imaging; Necrosis; Neoplasm Transplantation; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; ROC Curve; Squamous Cell Carcinoma of Head and Neck; Time Factors; Tomography, X-Ray Computed; Transplantation, Heterologous; Tumor Burden | 2012 |
Is image registration of fluorodeoxyglucose-positron emission tomography/computed tomography for head-and-neck cancer treatment planning necessary?
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Treatment Failure; Tumor Burden | 2012 |
Can "early" and "late"18F-FDG PET-CT be used as prognostic factors for the clinical outcome of patients with locally advanced head and neck cancer treated with radio-chemotherapy?
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
FDG PET/CT and diffusion-weighted imaging of head and neck squamous cell carcinoma: comparison of prognostic significance between primary tumor standardized uptake value and apparent diffusion coefficient.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Diffusion; Diffusion Magnetic Resonance Imaging; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2012 |
18F-FDG PET/CT for detecting distant metastases in patients with recurrent head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2012 |
Positron emission tomography in the detection of occult primary head and neck carcinoma: a retrospective study.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2012 |
Economic analysis of FDG-PET-guided management of the neck after primary chemoradiotherapy for node-positive head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neck Dissection; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2013 |
18F-fluorodeoxythymidine micro-positron-emission tomography versus 18F-fluorodeoxyglucose micro-positron-emission tomography for in vivo minimal residual disease imaging.
Topics: Animals; Carcinoma, Squamous Cell; Dideoxynucleosides; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Luminescent Measurements; Mice; Mice, Nude; Neoplasm, Residual; Positron-Emission Tomography; Prospective Studies; Squamous Cell Carcinoma of Head and Neck; Xenograft Model Antitumor Assays | 2013 |
PET/MRI in head and neck cancer: initial experience.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Lymph Nodes; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Whole Body Imaging | 2013 |
A gel tumour phantom for assessment of the accuracy of manual and automatic delineation of gross tumour volume from FDG-PET/CT.
Topics: Algorithms; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Gels; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Models, Anatomic; Models, Biological; Multimodal Imaging; Neoplasms; Pattern Recognition, Automated; Phantoms, Imaging; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Tumor Burden | 2013 |